This report will detail the complete range of sealants & glues technologies
used in traumatic, surgical and other wound closure, including tapes,
sutures/staples/mechanical closure, hemostats, fibrin sealants/glues and
medical adhesives and anti-adhesion products.
The report will detail current clinical and technology developments, with data
on products in development (detailing market status) and on the market; market
size and forecast; competitor market shares; competitor profiles; and market
opportunity. The report will provide full year actual data from 2011. The
report will provide a worldwide forecast to 2017 of the markets for these
technologies, with particular emphasis on the market impact of new
technologies through the forecast period. The report will provide specific
forecasts and shares of the worldwide market by segment for Americas (detail
for U.S., Rest of North America and Latin America), Europe (detail for United
Kingdom, German, France, Italy, Spain, Rest of Europe), Asia/Pacific (detail
for Japan, Korea, Rest of Asia/Pacific) and Rest of World.
The report will also provide background data on the surgical, disease and
traumatic wound patient populations targeted by current technologies and those
under development, and the current clinical practices in the management of
these patients, including the dynamics among the various clinical specialties
or subspecialties vying for patient population and facilitating or limiting
the growth of technologies. The report will establish the current worldwide
market size for major technology segments as a baseline for and projecting
growth in the market through 2017. The report will also assess and project the
composition of the market as technologies gain or lose relative market
performance over this period. The report will profile a minimum of 100
companies in this industry, providing data on their current products, current
market position and products under development.
Methodology
MedMarket Diligence Reports are produced through primary and secondary
research. Data is gathered from published sources on products and technologies
on the market and under development. Clinicians and industry representatives
are interviewed for their knowledge and insights on product development,
market development, clinical practice and trends associated with the evolving
use of technologies. Secondary data is used to corroborate and support
assessments and projections. Reports are written and researched by industry
insiders, whose familiarity with the companies, industry dynamics and other
marketplace specifics facilitate the research process and ensure high quality
and thorough reports.
About MedMarket
MedMarket Diligence provides tactical information and insight to the medical
products, investment and other industries on the status and outlook for
advanced medical technology.
Report Statistics
Publication Date:February 2012
Total Number of Pages:350
Total Number of Exhibits:60
Total Number of Company Profiles:122
Table of Contents
Table of Contents
EXECUTIVE SUMMARY
SECTION 1: CLINICAL NEED, CASELOAD AND PROCEDURE VOLUME
1.1. Anatomy and Physiology of Tissue Repair
1.2. The Skin
1.3. Internal Tissues and Organ
1.4. Wound Classification and Types
1.4.1. Classification by Morphology and Severity
1.4.2. Classification by Cause
1.4.3. Surgical Wounds
1.5. Caseload
1.5.1. Cardiovascular
1.5.5.1. Coronary Heart Disease
1.5.1.2. Dysfunctional Heart Valves
1.5.1.3. Peripheral Vascular Disorders
1.5.1.4. Abnormal Aortic Aneurysms
1.5.1.5. Drivers of Caseloads for Cardiac Surgery
1.5.2. Neurological
1.5.2.1. Stroke
1.5.2.2. Parkinson's Disease
1.5.2.3. Epilepsy
1.5.2.4. Traumatic Injury
1.5.2.5. Peripheral Nerve Treatment
1.5.2.6. Drivers of Neurological Surgery
1.5.3. Orthopedic
1.5.3.1. Hip Replacement
1.5.3.2. Knee Replacements
1.5.3.3. Cartilage Repair
1.5.3.4. Ligament Damage
1.5.3.5. Bone Grafting
1.5.3.6. Vertebral Disc Repair
1.5.3.7. Drivers of Orthopedic Surgery
1.5.4. Urological
1.5.4.1. Incontinence
1.5.4.2. Drivers of Urological Surgery
1.5.5. Dermatological
1.5.5.1. Burns
1.5.5.2. Pressure Ulcers
1.5.5.3. Diabetic Ulcers
1.5.5.4. Venous Ulcers
1.5.5.5. Plastic Surgery
1.5.5.6. Drivers of Dermatological Surgery
1.6. The Role of Modern Sealant, Securement and Hemostatic Products in
Surgery
1.6.1. Fibrin Sealants
1.6.2. High-Strength Glues
SECTION 2: SCIENCE, TECHNOLOGY, DEVELOPMENT, CLINICAL AND REGULATORY CHALLENGES
2.1. Tissue Healing
2.1.1. Hemostasis
2.1.2. Proliferation and Maturation
2.1.3. Factors That Affect Healing
2.2. Product Development
2.3. Development Timelines
2.3.1. Collagen and Thrombin Combination
2.3.2. Polyethylene Glycol Polymer (PEG)
2.3.3. Albumin Cross-Linked with Glutaraldehyde
2.3.4. Delivery Systems
2.4. Cost-Effectiveness
2.5. Regulatory Challenges
2.5.1. Approval Processes
2.5.2. History of Product Development
2.5.3. Regulatory Aspects
SECTION 3: PRODUCTS, TECHNOLOGIES, AND FORECAST OPPORTUNITY
3.1. Overview
3.1.1. Development Timeline
3.2. Sutures, Staples and other Mechanical Closure Devices
3.2.1. Sutures, Staples and Mechanical Closure Competitors and Products
3.2.2. Sutures, Staples and Mechanical Closure Products in Development
3.2.3. Sutures, Staples and Mechanical Closure Market Analysis and
Forecast
3.3. Tapes
3.3.1. Medical Tape Competitors and Products
3.3.2. Medical Tape Market Analysis and Forecast
3.4. Hemostats
3.4.1. Hemostat Competitors and Products
3.4.2. Hemostat Products in Development
3.4.3. Hemostat Market Analysis and Forecasts
3.5. Fibrin and Other Sealant Products
3.5.1. Fibrin and Other Sealant Competitors and Products
3.5.2. Fibrin and Other Sealant Products in Development
3.5.3. Fibrin and Other Sealant Market Analysis and Forecasts
3.6. High-Strength Medical Adhesives
3.6.1. High-Strength Medical Adhesive Competitors and Products
3.6.2. High-Strength Medical Adhesive Products in Development
3.6.3. High-Strength Medical Adhesive Market Analysis and Forecasts
3.7. Post-Surgical Adhesion Prevention
3.7.1. Post-Surgical Adhesion Prevention Competitors and Products
3.7.2. Post-Surgical Adhesion Prevention Products in Development
3.7.3. Post-Surgical Adhesion Prevention Market Analysis and Forecasts
3.8. Wound Closure and Securement Markets: Global and Regional Analysis
3.8.1. Americas
3.8.2. European Union
3.8.3. Asia-Pacific
3.8.4. Rest of World
3.9. Worldwide Markets By Country and Segment
3.9.1. Americas
3.9.1.1. United States
3.9.1.1.1. Sutures & Staples
3.9.1.1.2. Mechanical Closure
3.9.1.1.3. Tapes
3.9.1.1.4. Hemostats
3.9.1.1.5. Fibrin & Other Sealants
3.9.1.1.6. High-Strength Medical Adhesives
3.9.1.1.7. Post-Surgical Adhesion Prevention
3.9.1.2. Rest of North America
3.9.1.2.1. Sutures & Staples
3.9.1.2.2. Mechanical Closure
3.9.1.2.3. Tapes
3.9.1.2.4. Hemostats
3.9.1.2.5. Fibrin & Other Sealants
3.9.1.2.6. High-Strength Medical Adhesives
3.9.1.2.7. Post-Surgical Adhesion Prevention
3.9.1.3. Latin America
3.9.1.3.1. Sutures & Staples
3.9.1.3.2. Mechanical Closure
3.9.1.3.3. Tapes
3.9.1.3.4. Hemostats
3.9.1.3.5. Fibrin & Other Sealants
3.9.1.3.6. High-Strength Medical Adhesives
3.9.1.3.7. Post-Surgical Adhesion Prevention
3.9.2. European Union
3.9.2.1. United Kingdom
3.9.2.1.1. Sutures & Staples
3.9.2.1.2. Mechanical Closure
3.9.2.1.3. Tapes
3.9.2.1.4. Hemostats
3.9.2.1.5. Fibrin & Other Sealants
3.9.2.1.6. High-Strength Medical Adhesives
3.9.2.1.7. Post-Surgical Adhesion Prevention
3.9.2.2. Germany
3.9.2.2.1. Sutures & Staples
3.9.2.2.2. Mechanical Closure
3.9.2.2.3. Tapes
3.9.2.2.4. Hemostats
3.9.2.2.5. Fibrin & Other Sealants
3.9.2.2.6. High-Strength Medical Adhesives
3.9.2.2.7. Post-Surgical Adhesion Prevention
3.9.2.3. France
3.9.2.3.1. Sutures & Staples
3.9.2.3.2. Mechanical Closure
3.9.2.3.3. Tapes
3.9.2.3.4. Hemostats
3.9.2.3.5. Fibrin & Other Sealants
3.9.2.3.6. High-Strength Medical Adhesives
3.9.2.3.7. Post-Surgical Adhesion Prevention
3.9.2.4. Spain
3.9.2.4.1. Sutures & Staples
3.9.2.4.2. Mechanical Closure
3.9.2.4.3. Tapes
3.9.2.4.4. Hemostats
3.9.2.4.5. Fibrin & Other Sealants
3.9.2.4.6. High-Strength Medical Adhesives
3.9.2.4.7. Post-Surgical Adhesion Prevention
3.9.2.5. Italy
3.9.2.5.1. Sutures & Staples
3.9.2.5.2. Mechanical Closure
3.9.2.5.3. Tapes
3.9.2.5.4. Hemostats
3.9.2.5.5. Fibrin & Other Sealants
3.9.2.5.6. High-Strength Medical Adhesives
3.9.2.5.7. Post-Surgical Adhesion Prevention
3.9.2.6. Rest of Europe
3.9.2.6.1. Sutures & Staples
3.9.2.6.2. Mechanical Closure
3.9.2.6.3. Tapes
3.9.2.6.4. Hemostats
3.9.2.6.5. Fibrin & Other Sealants
3.9.2.6.6. High-Strength Medical Adhesives
3.9.2.6.7. Post-Surgical Adhesion Prevention
3.9.3. Asia-Pacific
3.9.3.1. Japan
3.9.3.1.1. Sutures & Staples
3.9.3.1.2. Mechanical Closure
3.9.3.1.3. Tapes
3.9.3.1.4. Hemostats
3.9.3.1.5. Fibrin & Other Sealants
3.9.3.1.6. High-Strength Medical Adhesives
3.9.3.1.7. Post-Surgical Adhesion Prevention
3.9.3.2. Korea
3.9.3.2.1. Sutures & Staples
3.9.3.2.2. Mechanical Closure
3.9.3.2.3. Tapes
3.9.3.2.4. Hemostats
3.9.3.2.5. Fibrin & Other Sealants
3.9.3.2.6. High-Strength Medical Adhesives
3.9.3.2.7. Post-Surgical Adhesion Prevention
3.9.3.3. Rest of Asia-Pacific
3.9.3.3.1. Sutures & Staples
3.9.3.3.2. Mechanical Closure
3.9.3.3.3. Tapes
3.9.3.3.4. Hemostats
3.9.3.3.5. Fibrin & Other Sealants
3.9.3.3.6. High-Strength Medical Adhesives
3.9.3.3.7. Post-Surgical Adhesion Prevention
3.9.4. Rest of World
3.9.4.1. Sutures & Staples
3.9.4.2. Mechanical Closure
3.9.4.3. Tapes
3.9.4.4. Hemostats
3.9.4.5. Fibrin & Other Sealants
3.9.4.6. High-Strength Medical Adhesives
3.9.4.7. Post-Surgical Adhesion Prevention
SECTION 4: COMPANY PROFILES
4.1. 3M
4.2. Abbott Laboratories
4.3. AccessClosure, Inc.
4.4. Adhesives Research, Inc.
4.5. Adhezion Biomedical, LLC
4.6. Advanced Medical Solutions Group plc/Medlogic Global
4.41. CSMG Technologies, Inc. (Live Tissue Connect, Inc.)
4.42. CuraMedical BV
4.43. Derma Sciences, Inc.
4.44. DuPont Applied BioSciences
4.45. Dynamic Techno Medicals Pvt. Ltd.
4.46. Entegrion, Inc.
4.47. Equimedical B.V.
4.48. Ferndale Laboratories
4.49. FibroGen, Inc.
4.50. FzioMed Inc.
4.51. Gelita Medical BV
4.52. GEM srl
4.53. Genzyme Biosurgery Inc.
4.54. GluStitch, Inc.
4.55. Graceduty Company Limited
4.56. Hartmann Group/Hartmann USA
4.57. HemCon Medical Technologies, Inc.
4.58. Hemostasis, LLC
4.59. HyperBranch Medical Technology, Inc.
4.60. Hy-Tape International
4.61. Incisive Surgical, Inc.
4.62. Innovasa Corporation
4.63. Integra Lifesciences Corporation
4.64. Interventional Therapies, LLC
4.65. Johnson & Johnson (Ethicon, Inc., Ethicon Endo-Surgery, Inc.,
Ethicon Biosurgery)
4.66. Kaketsuken (Chemo-Sero-Therapeutic Research Institute)
4.67. Kensey Nash Corporation
4.68. Kimberly-Clark Health Care
4.69. Kinetic Concepts, Inc.
4.70. Kookbo Chemicals Co., Ltd. (KB Chem.)
4.71. Kuros Biosurgery AG
4.72. Laboratoires Urgo (Urgo Medical)
4.73. LifeBond Ltd.
4.74. LifeScience PLUS
4.75. Lohmann & Rauscher
4.76. Marine Polymer Technologies, Inc.
4.77. Medafor, Inc.
4.78. Medisse
4.79. MedTrade Products, Ltd.
4.80. Meyer-Haake GmbH Medical Innovations
4.81. Molnlycke Health Care AB
4.82. Morris Innovative
4.83. Motex Healthcare Corp.
4.84. NeatStitch Ltd.
4.85. Neomend
4.86. Nobles Medical Technology
4.87. Nycomed (Takeda)
4.88. Ocular Therapeutix, Inc.
4.89. Omrix Biopharmaceuticals Inc. (Johnson & Johnson)
4.90. Opocrin S.p.A
4.91. Orthocon, Inc.
4.92. Orthovita, Inc. (Stryker)
4.93. Pathfinder Cell Therapy, Inc. (formerly SyntheMed)
4.94. Pfizer Inc.
4.95. Plasma Technologies, Inc.
4.96. Pluromed, Inc.
4.97. Polyganics BV
4.98. PolyHeal Ltd.
4.99. ProFibrix BV
4.100. Ranfac Corporation
4.101. Resorba Wundversorgung GmbH & Co. KG
4.102. Salient Surgical Technologies, Inc. (Medtronic)
4.103. Scion Cardio-Vascular, Inc.
4.104. Sea Run Holdings
4.105. Smith & Nephew plc
4.106. St. Jude Medical
4.107. Starch Medical, Inc.
4.108. STB Lifesaving Technologies, Inc.
4.109. Synovis Life Technologies
4.110. Teleflex Medical
4.111. Tenaxis Medical
4.112. ThermoGenesis Corporation
4.113. Thrombotargets Corp.
4.114. TissueSeal, LLC
4.115. Tissuemed Ltd.
4.116. Vascular Solutions, Inc.
4.117. Vivostat A/S
4.118. Wortham Laboratories, Inc.
4.119. Wound Care Technologies, Inc.
4.120. Z-Medica Corporation
4.121. Zimmer
4.122. ZymoGenetics, Inc. (Bristol-Myers Squibb)
APPENDIX: COMPANY DIRECTORY
Worldwide Market for Surgical Sealants, Glues, Wound Closure and Anti-Adhesion, 2012-2017 published by MedMarket Diligence in February 2, 2012. This report price starts from US $ 3950.
The contents of this page may be different from the latest version. Please contact us for details.
